To investigate whether the pattern of ACE-inhibitors use differ between indications in terms of persistence rate, continuation, discontinuation and switching.
. General characteristics of included patients stratified for different indications (N= 276,977patients).
Introduction:
Angiotensin converting enzyme inhibitors (ACE-inhibitors) are one of the most frequently prescribed groups of medications which are commonly used in the treatment of hypertension, heart failure, myocardial infarction and renal disease. A substantial number of patients discontinue therapy with ACE-inhibitors. 
Methods:
Design & setting: descriptive population-based cohort study in the Clinical Practice Research Datalink (CPRD) which contains the data of almost 12 million subjects in the UK collected by general practitioners.
Study population:
A cohort of patients older than 45 years who started ACE-inhibitor treatment between 2007 and 2014 were selected within the CPRD.
Follow up: Patients were followed until the end of the study period which was January 1st 2014, or the censor date which was the date a patient died or moved outside of the catchment area (loss of follow-up), whichever came first.
Indications: Indications for ACE-inhibitor treatment were retrieved from the medical records any time before or maximum one year after the first ACE-inhibitor prescription. Data analyses: 5-year persistence rates and the time to discontinuation among the different indications were calculated and compared using the Kaplan-Meier method and the log-rank test.
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